Regulatory science is ultimately a matter of trust. You need to trust that certain evidence, when obtained with certain methodologies, is sufficient to inform about a new medical product's safety and/or efficacy.

Viceconti, M., Serigado, A., Rousseau, C.F., Voisin, E.M. (2024). Possible Qualification Pathways for In Silico Methodologies. Berlin : Springer Cham [10.1007/978-3-031-48284-7_5].

Possible Qualification Pathways for In Silico Methodologies

Viceconti M.
;
2024

Abstract

Regulatory science is ultimately a matter of trust. You need to trust that certain evidence, when obtained with certain methodologies, is sufficient to inform about a new medical product's safety and/or efficacy.
2024
Toward Good Simulation Practice: Best Practices for the Use of Computational Modelling and Simulation in the Regulatory Process of Biomedical Products.
67
72
Viceconti, M., Serigado, A., Rousseau, C.F., Voisin, E.M. (2024). Possible Qualification Pathways for In Silico Methodologies. Berlin : Springer Cham [10.1007/978-3-031-48284-7_5].
Viceconti, M.; Serigado, A.; Rousseau, C. F.; Voisin, E. M.
File in questo prodotto:
File Dimensione Formato  
THE INVESTIGATOR.pdf

accesso aperto

Tipo: Versione (PDF) editoriale / Version Of Record
Licenza: Creative commons
Dimensione 101.94 kB
Formato Adobe PDF
101.94 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/971678
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact